Cavium (CAVM) Cuts Q4 Sales Guidance
Tweet
Share
E-mail
Get Alerts CAVM Hot Sheet
Price: $86.23 --0%
Financial Fact:
Income (loss) from operations: -94.24M
Today's EPS Names:
CCEL, MHGU, FNGR, More
Financial Fact:
Income (loss) from operations: -94.24M
Today's EPS Names:
CCEL, MHGU, FNGR, More
Join SI Premium – FREE
Cavium (Nasdaq: CAVM) now sees Q4 sales $56-$57 million, which compares to the Street estimate of $61.6 million.
The company noted that revenues have been weaker than expected across both the enterprise and service provider as well as the broadband and consumer market segments, and further exasperated by a larger than expected impact of a hub transition at one of its major customers. The company believes that it under shipped to customer end demand in the fourth quarter. Gross margins for the fourth quarter of 2011 are expected to be approximately one percentage point lower than the company's previous guidance, due to the lower sales volume.
The company noted that revenues have been weaker than expected across both the enterprise and service provider as well as the broadband and consumer market segments, and further exasperated by a larger than expected impact of a hub transition at one of its major customers. The company believes that it under shipped to customer end demand in the fourth quarter. Gross margins for the fourth quarter of 2011 are expected to be approximately one percentage point lower than the company's previous guidance, due to the lower sales volume.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HCA Healthcare cuts 2026 profit outlook on insurance exchange losses
- Elevance Health Inc. (ELV) Tops Q2 EPS by 124c, raises guidance
- Virtu Financial posts Q2 2026 preliminary results, seeks $400M loan
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
